Embolization Coils Market Value to reach US$ 1,954.56 Million by 2032: Fact.MR Analysis
Embolization is one of the most accepted modalities of cancer treatment in patients with a variety of clinical scenarios. Hence, the rising burden of cancer is giving growth to the embolization procedures in this region.
Rockville, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The global embolization coils market size is expected to surpass an impressive valuation of US$ 1,200 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2022 to 2032, reaching a market value of US$ 1,954.56 Million. Factors such as increasing prevalence of vascular diseases, technological advancements in embolization products and procedures, increasing research and development activities, and growing demand for minimally invasive procedures are driving the market growth.Cardiovascular diseases (CVDs) commonly include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Factors such as tobacco use, an unhealthy diet, and physical inactivity increase the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, and they affect more people than any other disease.
The rise in prevalence of cardiac aneurysms is growing across the world. For instance, to the Society for Vascular Surgery (SVS) it is stated that every year in the US 2 million people are diagnosed with an abdominal aortic aneurysm. It is also stated that a rupture abdominal aortic aneurysm is the 15th leading cause of death in the country. It is most commonly seen in those older than 55 years of age. Therefore, the rise in the prevalence of cardiac aneurysms is fuelling the growth of the embolization coils market.
*Download a Free Sample Copy of this Report -* *https://www.factmr.com/connectus/sample?flag=S&rep_id=8070*
*Key Takeaways from Market Study*
· The global Embolization Coils market is expected to garner a market value of US$ 1,200 Million
· Market is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2022 to 2032.
· The Europe embolization coils market size is anticipated to register commendable growth, with the United Kingdom acquiring a major share.
· North America was the leading regional segment in terms of revenue and market share.
· Based on type, the detachable coil segment holds a larger market share.
· Based on application, In 2022, the neurology segment holds the largest share of the market.
· Based on end users, the hospital segment holds the largest share of the market.“Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions. They are used as an alternative to surgical embolization to cut the blood supply to the tumor. It is used to treat various types of diseases, such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases,” says an analyst at Future Market Insights.
*Key Segments Profiled in the Embolization Coils Market Industry Survey*
· *By Type :*
· Detachable Coil
· Pushable Coil
· *By Application :*
· Neurology
· Cardiology
· Urology
· Oncology
· Peripheral Vascular Disease
· Other
· *By End-user :*
· Hospitals
· Cardio Center
· Ambulatory Center
· Others
· *By Material :*
· Platinum
· Platinum & Hydrogel
· Platinum Tungsten Alloy*Get Customization on this Report fo**r Specific Research Solutions **–* *https://www.factmr.com/connectus/sample?flag=RC&rep_id=8070*
*Market Competition:*
· In July 2021, Terumo Medical Corporation (TMC) introduced its AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature.
· In April 2021, the US Food and Drug Administration (FDA) approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was indicated primarily for brain aneurysms. Shield Technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.
· In August 2022, MicroPort Scientific Corporation announced that it has received approval from the Colombian Institute for Drug and Food Surveillance (INVIMA) for its MinosTM Abdominal Aortic Stent-Graft and Delivery System. As a brand new abdominal aortic stent-graft system independently developed by Endovastec™, the Minos™ System is designed for the interventional therapy of infrarenal aortic aneurysms. It is the first domestically made stent-graft system which features an ultra-low profile delivery system with an outer diameter of 14F.
· Boston Scientific Corporation offers the Pushable 0.018” and 0.035” Embolization Coils. These coils offer successful embolization through a systematic approach including guidewires, catheters, coils, and/or embolic materials. The VortX 18 and 35 Vascular Occlusion Coils are designed with a proprietary conical shape and an apex-first deployment. VortX Coils are pushable coils designed to provide compact, complete vascular occlusion and efficient embolization.
*Key Companies Profiled*
· Terumo Corporation
· Medtronic plc
· Boston Scientific Corporation
· Stryker Corporation
· KANEKA CORPORATION
· MicroPort Scientific Corporation
· Penumbra, Inc.
· Cook Medical LLC
· Johnson & Johnson Services, Inc.
· Shape Memory Medical INC
*Explore Our Safe & Secure Payment Options for Quick Buy **– **https://www.factmr.com/checkout/8070*
*More Valuable Insights** *
Fact.MR, in its new offering, presents an unbiased analysis of the global Embolization Coils market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of Type (Detachable Coil and Pushable Coil), Material (Platinum, Platinum & Hydrogel, and Platinum Tungsten Alloy), Application (Neurology, Cardiology, Urology, Oncology, Peripheral Vascular Disease, and Other), and End User (Hospital, Cardio Center, Ambulatory Center, and Other) & Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
*Check out more related studies published by Fact.MR Research: *
*Neurology Devices Market**: *Worldwide sales of neurology devices are anticipated to increase at a CAGR of 6.2% from 2022 to 2027. At present, the global neurology devices market is valued at US$ 9.6 billion and is projected to reach a market size of US$ 13 billion by 2027. Demand for cerebrospinal fluid management devices is expected to rise faster at a CAGR of 6.5% through 2027. Segment growth is attributed to the incorporation of new and improved sensors in cerebrospinal fluid management devices to enhance the accuracy of diagnosis.
*Neurology Diagnostics Devices Market**: *At the end of 2021, the global neurology diagnostics devices market was valued at US$ 8.24 billion and is anticipated to reach US$ 21.1 billion by 2032, expanding at a high CAGR of 8.9% over the 2022-2032 time frame. As per a detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, CT Scanners dominated the global market in 2021 accounting for 37.3% market share.
*Cardiology Genomic Testing Market**: *Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases.
*Surgical and Interventional Cardiology Devices Market**: *Numerous surgical and intervention procedures are performed for treatment of cardiovascular disorders. Surgical and interventional cardiology devices are designed to maintain the natural rhythm of heartbeats. Due to unhealthy life style and increasing geriatric population the rate of heart attacks and cardiovascular disorder has increased immensely in recent years. According to WHO 31% deaths worldwide is due to cardiovascular disorder.
*Urology Devices Market**: *The global urology devices market is evaluated at USD 11.8 Billion in 2022 and is forecast to outshine USD 21.7 Billion by 2032, mounting at a CAGR of 6.3% from 2022 to 2032. Urology is the branch of medicine that deals with the diseases associated with the male & female urinary tract and male reproductive system. These diseases include bladder control problems, kidney stones, urinary tract infections, prostate problems, cancer, and others.
*About Us:*
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
*Specialties: *Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.
*Contact:*
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
*Email: **sales@factmr.com*
Tel: +1 (628) 251-1583